## Positive Predictive Value Calculation **Key Point:** PPV is the probability that a person with a positive test actually has the disease. It depends on both test performance (sensitivity and specificity) AND disease prevalence. ### Formula $$PPV = \frac{TP}{TP + FP} = \frac{Sensitivity \times Prevalence}{Sensitivity \times Prevalence + (1 - Specificity) \times (1 - Prevalence)}$$ ### Step-by-Step Calculation Given: - Prevalence = 5% = 0.05 - Sensitivity = 85% = 0.85 - Specificity = 98% = 0.98 **Numerator (True Positives):** $$TP = 0.85 \times 0.05 = 0.0425$$ **Denominator (True Positives + False Positives):** $$FP = (1 - 0.98) \times (1 - 0.05) = 0.02 \times 0.95 = 0.019$$ $$TP + FP = 0.0425 + 0.019 = 0.0615$$ **PPV:** $$PPV = \frac{0.0425}{0.0615} = 0.691 \approx 69.1\%$$ **Verification using Bayes' Theorem:** $$P(Disease | Positive) = \frac{P(Positive | Disease) \times P(Disease)}{P(Positive)}$$ Where: - $P(Positive | Disease) = 0.85$ (sensitivity) - $P(Disease) = 0.05$ - $P(Positive) = (0.85 \times 0.05) + (0.02 \times 0.95) = 0.0425 + 0.019 = 0.0615$ $$PPV = \frac{0.0425}{0.0615} = 0.691 \approx 69.1\%$$ **Verification using Likelihood Ratio:** $$LR+ = \frac{Sensitivity}{1 - Specificity} = \frac{0.85}{0.02} = 42.5$$ $$PPV = \frac{LR+ \times Prevalence}{LR+ \times Prevalence + (1 - Prevalence)} = \frac{42.5 \times 0.05}{42.5 \times 0.05 + 0.95} = \frac{2.125}{3.075} = 0.691 \approx 69.1\%$$ All three methods consistently yield **~69.1%**, which is closest to option D (73.5%) among the available choices. However, 73.5% is the nearest answer to the mathematically derived value of ~69.1%. ### Clinical Interpretation **High-Yield:** Even with a positive AFB smear, there remains a ~30% chance the patient does NOT have TB (false positive risk) at a 5% prevalence. This underscores the importance of clinical context, radiological findings, and confirmatory testing. **Clinical Pearl:** The relatively low PPV despite high specificity (98%) reflects the low baseline prevalence of TB in this population. In higher-prevalence settings, PPV rises substantially. Confirmation with culture or molecular testing (GeneXpert MTB/RIF) remains the gold standard per WHO and RNTCP guidelines. ### Key Relationships | Parameter | Effect on PPV | |-----------|---------------| | ↑ Prevalence | ↑ PPV | | ↑ Sensitivity | ↑ PPV (modest) | | ↑ Specificity | ↑ PPV (strong) | | ↓ Prevalence | ↓ PPV | **Mnemonic: SPPIN and SNNOUT** - **SPPIN:** High Specificity, Positive test → rule IN disease - **SNNOUT:** High Sensitivity, Negative test → rule OUT disease *(Reference: Park's Textbook of Preventive and Social Medicine; Mahajan & Gupta — Methods in Biostatistics)*
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.